Hamed Alavi - EnVVeno Medical Senior Officer
| NVNO Stock | USD 3.11 0.08 2.51% |
Executive
Hamed Alavi is Senior Officer of enVVeno Medical Corp
| Age | 41 |
| Address | 70 Doppler, Irvine, CA, United States, 92618 |
| Phone | 949 261 2900 |
| Web | https://www.envveno.com |
Hamed Alavi Latest Insider Activity
Tracking and analyzing the buying and selling activities of Hamed Alavi against EnVVeno Medical stock is an integral part of due diligence when investing in EnVVeno Medical. Hamed Alavi insider activity provides valuable insight into whether EnVVeno Medical is net buyers or sellers over its current business cycle. Note, EnVVeno Medical insiders must abide by specific rules, including filing SEC forms every time they buy or sell EnVVeno Medical'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
Hamed Alavi over six months ago Disposition of 8334 shares by Hamed Alavi of EnVVeno Medical at 3.59 subject to Rule 16b-3 | ||
Hamed Alavi over six months ago Disposition of 8334 shares by Hamed Alavi of EnVVeno Medical at 3.59 subject to Rule 16b-3 | ||
Hamed Alavi over six months ago Disposition of 8334 shares by Hamed Alavi of EnVVeno Medical at 6.22 subject to Rule 16b-3 |
EnVVeno Medical Management Efficiency
The company has return on total asset (ROA) of (0.3728) % which means that it has lost $0.3728 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.5877) %, meaning that it created substantial loss on money invested by shareholders. EnVVeno Medical's management efficiency ratios could be used to measure how well EnVVeno Medical manages its routine affairs as well as how well it operates its assets and liabilities. As of the 1st of December 2024, Return On Tangible Assets is likely to drop to -0.51. In addition to that, Return On Capital Employed is likely to grow to -0.51. At this time, EnVVeno Medical's Total Assets are very stable compared to the past year. As of the 1st of December 2024, Non Current Assets Total is likely to grow to about 1.8 M, while Non Currrent Assets Other are likely to drop about 26.5 K.Similar Executives
| Showing other executives | EXECUTIVE Age | ||
| Maureen OConnell | Rxsight | N/A | |
| Bradley Nagel | Electromed | 42 | |
| CFA CPA | Axogen Inc | 50 | |
| Roberto Donadello | Orthofix Medical | N/A | |
| Isabelle Billet | Axogen Inc | 62 | |
| Harold Tamayo | Axogen Inc | N/A | |
| Stephanie Walsh | Orthofix Medical | N/A | |
| Jrme Erath | Pulmonx Corp | N/A | |
| Oliver Moravcevic | Rxsight | N/A | |
| Dan Yarbrough | Orthofix Medical | N/A | |
| Steve Everly | Rxsight | N/A | |
| Matthew III | LivaNova PLC | N/A | |
| Todd Puckett | Axogen Inc | N/A | |
| Trui Hebbelinck | LivaNova PLC | 52 | |
| Julie Andrews | Orthofix Medical | 53 | |
| Jill Mason | Orthofix Medical | N/A | |
| David JD | Pulmonx Corp | 63 | |
| Rebecca Williston | Rxsight | N/A | |
| Sarah Huber | Pulmonx Corp | N/A | |
| Marcee Maroney | Pulmonx Corp | 54 | |
| Michael Donovan | Axogen Inc | 59 | |
Management Performance
| Return On Equity | -0.59 | ||||
| Return On Asset | -0.37 |
enVVeno Medical Corp Leadership Team
Elected by the shareholders, the EnVVeno Medical's board of directors comprises two types of representatives: EnVVeno Medical inside directors who are chosen from within the company, and outside directors, selected externally and held independent of EnVVeno. The board's role is to monitor EnVVeno Medical's management team and ensure that shareholders' interests are well served. EnVVeno Medical's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, EnVVeno Medical's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Andrew Cormack, Chief Officer | ||
| Craig Glynn, Treasurer CFO | ||
| Benedict MD, Chief States | ||
| Sandy Prietto, Vice Marketing | ||
| Robert Berman, CEO Director | ||
| Marc MD, Senior Officer | ||
| Hamed Alavi, Senior Officer | ||
| Warren Hancock, Cofounder |
EnVVeno Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is EnVVeno Medical a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.59 | ||||
| Return On Asset | -0.37 | ||||
| Current Valuation | 7.31 M | ||||
| Shares Outstanding | 17.54 M | ||||
| Shares Owned By Insiders | 0.29 % | ||||
| Shares Owned By Institutions | 29.76 % | ||||
| Number Of Shares Shorted | 510.65 K | ||||
| Price To Book | 1.15 X | ||||
| EBITDA | (25.02 M) | ||||
| Net Income | (23.52 M) |
Pair Trading with EnVVeno Medical
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if EnVVeno Medical position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in EnVVeno Medical will appreciate offsetting losses from the drop in the long position's value.Moving together with EnVVeno Stock
Moving against EnVVeno Stock
| 0.72 | ELMD | Electromed | PairCorr |
| 0.66 | MD | Mednax Inc | PairCorr |
| 0.6 | DOCS | Doximity | PairCorr |
| 0.51 | OM | Outset Medical | PairCorr |
| 0.45 | VREX | Varex Imaging Corp | PairCorr |
The ability to find closely correlated positions to EnVVeno Medical could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace EnVVeno Medical when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back EnVVeno Medical - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling enVVeno Medical Corp to buy it.
The correlation of EnVVeno Medical is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as EnVVeno Medical moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if enVVeno Medical Corp moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for EnVVeno Medical can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in enVVeno Medical Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of EnVVeno Medical. If investors know EnVVeno will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about EnVVeno Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.29) | Return On Assets (0.37) | Return On Equity (0.59) |
The market value of enVVeno Medical Corp is measured differently than its book value, which is the value of EnVVeno that is recorded on the company's balance sheet. Investors also form their own opinion of EnVVeno Medical's value that differs from its market value or its book value, called intrinsic value, which is EnVVeno Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because EnVVeno Medical's market value can be influenced by many factors that don't directly affect EnVVeno Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between EnVVeno Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if EnVVeno Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, EnVVeno Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.